Doximity Inc (DOCS)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NYSE
Market Cap: $5.95B
Last updated: Nov 17, 2026 at 11:03 AM ET
Doximity Inc (DOCS) Stock Forecast
Analysts expect Doximity (DOCS) to earn $1.35 per share in the fiscal year ending Mar 31, 2027, on revenue of $680.26M. Of 21 analysts, 8 rate the stock Buy or Strong Buy, 11 Hold and 2 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 1 estimate for the fiscal year ending Mar 31, 2027 was revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 21 ratings average 2.52, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 38% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 5 | 23.8% |
| Buy | 3 | 14.3% |
| Hold | 11 | 52.4% |
| Sell | 1 | 4.8% |
| Strong Sell | 1 | 4.8% |
- Consensus
- Hold
- Total analysts
- 21
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 14.8% and revenue estimates rise 6.3%.
- Fiscal year ending Mar 31, 2027
- $1.35
- EPS consensus, revenue $680.26M
- Fiscal year ending Mar 31, 2028
- $1.55
- EPS consensus, revenue $722.83M
- Next report
- Feb 3, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Mar 31, 2027 | $1.35 | $1.27 to $1.45 | 18 | $680.26M | $673.30M to $683.20M | 20 |
| Mar 31, 2028 | $1.55 | $1.41 to $1.75 | 16 | $722.83M | $693.48M to $748.40M | 18 |
Quarterly Estimates
The EPS consensus falls from $0.44 for the quarter ending Dec 31, 2026 to $0.26 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.44 | $0.39 to $0.51 | 17 | $195.53M | $195.00M to $196.20M | 17 |
| Mar 31, 2027 | $0.26 | $0.22 to $0.32 | 24 | $157.52M | $147.15M to $171.99M | 21 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 13 upward and 2 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Mar 31, 2027 | 1 | 1 |
| Quarter ending Dec 31, 2026 | 12 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Mar 31, 2027 has fallen 0.7% from $1.36.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Mar 31, 2027 | $1.35 | $1.35 | $1.35 | $1.35 | $1.36 | -1.2% |
| Fiscal year ending Mar 31, 2028 | $1.55 | $1.56 | $1.56 | $1.55 | $1.56 | -0.5% |
| Quarter ending Dec 31, 2026 | $0.44 | $0.42 | $0.42 | $0.42 | $0.42 | +5.8% |
Frequently Asked Questions About DOCS
What is the DOCS stock forecast?
Consensus analyst estimates put Doximity's EPS at $1.35 for the fiscal year ending Mar 31, 2027, on revenue of $680.26M. The consensus rating from 21 analysts is Hold.
How do analysts rate DOCS stock?
Of 21 analysts covering Doximity, 5 rate it Strong Buy, 3 Buy, 11 Hold, 1 Sell and 1 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from DOCS next year?
For the fiscal year ending Mar 31, 2027, the consensus EPS estimate is $1.35, with estimates from $1.27 to $1.45 from 18 analysts. For the fiscal year ending Mar 31, 2028, the consensus EPS estimate is $1.55, with estimates from $1.41 to $1.75 from 16 analysts.
What revenue do analysts expect from Doximity next year?
For the fiscal year ending Mar 31, 2027, the consensus revenue estimate is $680.26M, with estimates from $673.30M to $683.20M. For the fiscal year ending Mar 31, 2028, the consensus revenue estimate is $722.83M, with estimates from $693.48M to $748.40M.
How many analysts cover DOCS?
21 analysts rate Doximity stock, and 18 analysts estimate its EPS for the fiscal year ending Mar 31, 2027.
DOCS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts